These results were later echoed by those of another group, reporting that 68% of the breast tumours analysed exhibited nuclear pSTAT3, and the enrichment of STAT3 signature genes, considered to potentially represent ‘critical effectors of STAT3 activation in malignancy’ [63]. Here, STAT3 is linked to breast neoplasm.